Contact

Together, let's redefine cancer treatment

Submit your information to learn more about Salspera, Saltikva®, and our pipeline — or email us directly at info@salspera.com.

Send us a message

This will open your email app with the message ready to send to info@salspera.com.

Email

info@salspera.com

About Salspera

A privately held, privately funded biopharma company developing Saltikva®, a Live Biopharmaceutical (LBP) immunotherapy for advanced pancreatic cancer and other aggressive solid tumors.